What is Zymeworks's stock issuance proceeds?

Zymeworks (ZYME) reported stock issuance proceeds of $8.72M in Q1 2026.

How has Zymeworks's stock issuance proceeds changed year-over-year?

Zymeworks's stock issuance proceeds increased by 1029.1% year-over-year, from $772K to $8.72M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Zymeworks ZYME Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

AnaptysBio, Inc.ANAB

$14.02M+4,735%

Viridian Therapeutics, Inc.VRDN

$0-100%

Stoke Therapeutics, Inc.STOK

$3.21M+219%

Nurix Therapeutics, Inc.NRIX

$18M—

Septerna, Inc.SEPN

$333K+405%

Apogee Therapeutics, Inc.APGE

$378.17M—

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.79B+125%

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's stock issuance proceeds?: Zymeworks (ZYME) reported stock issuance proceeds of $8.72M in Q1 2026.
How has Zymeworks's stock issuance proceeds changed year-over-year?: Zymeworks's stock issuance proceeds increased by 1029.1% year-over-year, from $772K to $8.72M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.